Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15–25 years: A phase IV randomized comparative study

Autor: Selvamuthu Poongulali, Sylviane Poncelet, Silvana Maria Quintana, Sanjoy K Datta, Kiat Ruxrungtham, Lan Lin, Beatriz Grinsztejn, Khuanchai Supparatpinyo, Monique Dodet, Florence Thomas-Jooris, Nagalingeswaran Kumarasamy, Frank Struyf, Julio Cesar Teixeira, Naveen Karkada, Fernanda Tavares-da-Silva, Vinay Kulkarni, Smita Joshi, Nicolas Folschweiller, Dorothee Meric Camilleri, Bruno Salaun, Ploenchan Chetchotisakd, Dominique Descamps, Gary Dubin, Tawee Chotpitayasunondh, Luciano Zubaran Goldani, Cecilia Roteli-Martins, Damien Friel, Marjan Hezareh, Partha Basu

Publikováno v: EClinicalMedicine
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

Background Women living with HIV (WLWH) are at higher risk of acquisition and progression of human papillomavirus (HPV) infection. Evidence on effect of HPV vaccination in this population is limited. Methods This phase IV randomized controlled observ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b6d19612db6b5233527478783cf83c
https://doi.org/10.1016/j.eclinm.2020.100353